IMU 6.10% 7.7¢ imugene limited

Sheer scale of Celularity Deal!

  1. 3,022 Posts.
    lightbulb Created with Sketch. 6486

    M
    orning all, I have put together a few thought about the sheer size and scope of the Imugene/Celularity Partnership and why the details have not been even been nutted out as yet.

    Thanks to Paulfool for finding and sharing the video about Celularity’s Directors. This is worth watching several times.

    Peter Diamandis has made it his life’s work to make life better for all of humanity through science and technology. In his books ‘ABUNDANCE’ and ‘BOLD’ he lays out the map to a better planet for humanity.

    https://en.m.wikipedia.org/wiki/Peter_Diamandis

    He also coined the term ‘Global and Scaleable’. To create a super successful business , it needs to be Global and Scaleable which is the essence of the digital revolution.


    It’s this concept that is the really big news for IMU shareholders and cancer sufferers alike. MoIMU has a stable of amazing technology for treating cancers. We needed a CarT partner to give us a perpendicular combination therapy that our amazing team at IMU believe to be the key to treating cancer. There are likely to be several companies that could have provided that technology. But only one, Celularity could make our CF33/Cd19 therapy global and Scaleable.

    That is what makes this announcement, our biggest news so far. Celularity’s use of Placenta derived Stem cells therapies bypass and rejection from the patients own immune system. They are therefore universal. They can also be manufactured cheaply with a stable shelf life.

    As was described with such excitement by Dr Hariri and Leslie Chong in the recent webinar, this partnership will produce a one size fits all cancer therapy that is both Global and Scaleable.

    Because this treatment will work in all cancers and all patients, it is the absolute holy grail of cancers therapies. And as was posted by Valueadd a few days ago, some animal models can clearly depict how the drugs will work in humans. This is one of those drugs.

    The IMU/Celularity partnership is on the cusp of destroying the very lucrative cancer industry and replacing it with a one size fits all cancer treatment that is cheap enough that every single person on the planet will have access to it.

    People will go to a clinic, get diagnosed as a cancer sufferer, and be given an injection off the shelf to cure their cancer. This whole concept is perfectly aligned to Peter Diamandis ethos on life and technology.

    If you missed out on buying into the digital revolution via Microsoft, Apple, Facebook, Amazon,, when they were dirt cheap, you can now partake of this opportunity via Celularity or Imugene.

    I would highly recommend readings Diamandis books or finding his interviews on podcast or YouTube to fully grasp how big this deal is.



    https://youtu.be/qLtXS8myIxo
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
7.7¢
Change
-0.005(6.10%)
Mkt cap ! $563.6M
Open High Low Value Volume
8.2¢ 8.3¢ 7.6¢ $1.931M 24.42M

Buyers (Bids)

No. Vol. Price($)
14 1392733 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 140950 2
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
7.7¢
  Change
-0.005 ( 6.71 %)
Open High Low Volume
8.2¢ 8.3¢ 7.6¢ 9515046
Last updated 15.59pm 06/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.